Characterization of Vitreous B-Cell Infiltrates in Patients with Primary Ocular Lymphoma, Using CDR3 Size Polymorphism Analysis of Antibody Transcripts

Investigative Ophthalmology and Visual Science

Volumn 44, Issue 12, 2003, Pages 5235-5241

  Gorochov, Guy ^a,b   Parizot, Christophe ^a,b   Bodaghi, Bahram ^b   Raphael, Darren ^a   Cassoux, Nathalie ^b   Merle Beral, Hélène ^b   Debré, Patrice ^a   LeHoang, Phuc ^b  

^a INSERM   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CDR3 ANTIGEN; INTERLEUKIN 10; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; B LYMPHOCYTE; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EYE CANCER; FEMALE; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMETHOD COMPARISON; LYMPHOMA; MALE; MOLECULAR CLONING; POLYCLONAL ACTIVATION; PRIMARY OCULAR LYMPHOMA; PRIORITY JOURNAL; TUMOR IMMUNITY; UVEITIS; VITREOUS DISEASE;

ADULT; AGED; AGED, 80 AND OVER; B-LYMPHOCYTES; COMPLEMENTARITY DETERMINING REGIONS; DNA, NEOPLASM; EYE NEOPLASMS; FEMALE; HUMANS; INTERLEUKIN-10; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VITRECTOMY; VITREOUS BODY;

EID: 0344420044     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.03-0035     Document Type: Article

References (33)

1. Freeman CR, Shustik C, Brisson ML, Meagher-Villemure K, Dylewski I. Primary malignant lymphoma of the central nervous system. Cancer. 1986;5:1106-1111.
2. Fine HA, Mayer RJ. Primary central nervous system lymphoma. Ann Intern Med. 1993;11:1093-1104.
3. Angioi-Duprez K, Taillandier L, Gerin M, Berrod JP, George JL, Maalouf T. Ocular involvement during primary central nervous system lymphoma (in French). J Fr Ophtalmol. 2002;2:147-153.
4. Corn BW, Marcus SM, Topham A, Hauck W, Curran WJ Jr. Will primary central nervous system lymphoma be the most frequent brain tumor diagnosed in the year 2000? Cancer. 1997;12:2409-2413.
5. Chan CC, Buggage RR, Nussenblatt RB. Intraocular lymphoma. Curr Opin Ophthalmol. 2002;6:411-418.
6. Buggage RR, Chan CC, Nussenblatt RB. Ocular manifestations of central nervous system lymphoma. Curr Opin Oncol. 2001;13:137-142.
7. Velez G, Chan CC, Csaky KG. Fluorescein angiographic findings in primary intraocular lymphoma. Retina. 2002;1:37-43.
8. Akpek EK, Ahmed I, Hochberg FH, et al. Intraocular-central nervous system lymphoma: clinical features, diagnosis, and outcomes. Ophthalmology. 1999;9:1805-1810.
9. Cassoux N, Merle-Beral H, Leblond V, et al. Ocular and central nervous system lymphoma: clinical features and diagnosis. Ocul Immunol Inflamm. 2000;4:243-250.
10. Freeman LN, Schachat AP, Knox DL, Michels RG, Green WR. Clinical features, laboratory investigations, and survival in ocular reticulum cell sarcoma. Ophthalmology. 1987;12:1631-1639.
11. Peterson K, Gordon KB, Heinemann MH, DeAngelis LM. The clinical spectrum of ocular lymphoma. Cancer. 1993;3:843-849.
12. Whitcup SM, de Smet MD, Rubin BI, et al. Intraocular lymphoma: clinical and histopathologic diagnosis. Ophthalmology. 1993;9:1399-1406.
13. Tuaillon N, Chan CC. Molecular analysis of primary central nervous system and primary intraocular lymphomas. Curr Mol Med. 2001;2:259-272.
14. Whitcup SM, Chan CC, Buggage RR, Nussenblatt RB, Byrnes GA, Rubin BI. Improving the diagnostic yield of vitrectomy for intraocular lymphoma (Letter). Arch Ophthalmol. 2000;3:446.
15. Chan CC, Whitcup SM, Solomon D, Nussenblatt RB. Interleukin-10 in the vitreous of patients with primary intraocular lymphoma. Am J Ophthalmol. 1995;5:671-673.
16. Ongkosuwito JV, Feron EJ, van Doomik CE, et al. Analysis of immunoregulatory cytokines in ocular fluid samples from patients with uveitis. Invest Ophthalmol Vis Sci. 1998;13:2659-2665.
17. Whitcup SM, Stark-Vancs V, Wittes RE, et al. Association of interleukin 10 in the vitreous and cerebrospinal fluid and primary central nervous system lymphoma. Arch Ophthalmol. 1997;9:1157-1160.
18. Buggage RR, Whitcup SM, Nussenblatt RB, Chan CC. Using interleukin 10 to interleukin 6 ratio to distinguish primary intraocular lymphoma and uveitis. Invest Ophthalmol Vis Sci. 1999;10:2462-2463.
19. Akpek EK, Maca SM, Christen WG, Foster CS. Elevated vitreous interleukin-10 level is not diagnostic of intraocular-central nervous system lymphoma. Ophthalmology. 1999;12:2291-2295.
20. Chan CC, Shen D, Nussenblatt RB, Boni R, Zhuang Z. Detection of molecular changes in primary intraocular lymphoma by microdissection and polymerase chain reaction. Diagn Mol Pathol. 1998;1:63-64.
21. Shen DF, Zhuang Z, LeHoang P, et al. Utility of microdissection and polymerase chain reaction for the detection of immunoglobulin gene rearrangement and translocation in primary intraocular lymphoma. Ophthalmology. 1998;9:1664-1669.
22. Honjo T, Alt FW. Immunoglobulin Genes. 2nd ed. London: Academic Press; 1995.
23. Pannetier C, Cochet M, Darche S, Casrouge A, Zoller M, Kourilsky P. The sizes of the CDR3 hypervariable regions of the murine T-cell receptor beta chains vary as a function of the recombined germ-line segments. Proc Natl Acad Sci USA. 1993;9:4319-4323.
24. Aubin J, Davi F, Nguyen-Salomon F, et al. Description of a novel FR1 IgH PCR strategy and its comparison with three other strategies for the detection of clonality in B cell malignancies. Leukemia. 1995;3:471-479.
25. Gorochov G, Neumann AU, Kereveur A, et al. Perturbation of CD4+ and CD8+ T-cell repertoires during progression to AIDS and regulation of the CD4+ repertoire during antiviral therapy. Nat Med. 1998;2:215-221.
26. Bachelez H, Hadida F, Parizot C, et al. Oligoclonal expansion of HIV-specific cytotoxic CD8 T lymphocytes in the skin of HIV-1-infected patients with cutaneous pseudolymphoma. J Clin Invest. 1998;11:2506-2516.
27. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;1:156-159.
28. Kabat E, Wu T, Perry H, Gottesman K, Foeller C. Sequences of Proteins of Immunological Interest, Bethesda, MD: US Department of Health and Human Services, National Institutes of Health; 1991.
29. Gorski J, Yassai M, Zhu X, et al. Circulating T cell repertoire complexity in normal individuals and bone marrow recipients analyzed by CDR3 size spectratyping: correlation with immune status. J Immunol. 1994;10:5109-5119.
30. Delassus S, Gey A, Darche S, Cumano A, Roth C, Kourilsky P. PCR-based analysis of the murine immunoglobulin heavy-chain repertoire. J Immunol Methods. 1995;2:219-229.
31. Baranzini SE, Jeong MC, Butunoi C, Murray RS, Bernard CC, Oksenberg JR. B cell repertoire diversity and clonal expansion in multiple sclerosis brain lesions. J Immunol. 1999;9:5133-5144.
32. Moshous D, Pannetier C, Chasseval RR, et al. Partial T and B lymphocyte immunodeficiency and predisposition to lymphoma in patients with hypomorphic mutations in Artemis. J Clin Invest. 2003;3:381-387.
33. Mutimer HP, Akatsuka Y, Manley T, et al. Association between immune recovery uveitis and a diverse intraocular cytomegalovirus-specific cytotoxic T cell response. J Infect Dis. 2002;5:701-705.